• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗凝治疗的治疗期望、便利性及满意度:澳大利亚昆士兰州东南部患者的认知

Treatment Expectations, Convenience, and Satisfaction with Anticoagulant Treatment: Perceptions of Patients in South-East Queensland, Australia.

作者信息

Gospos Jonathan, Bernaitis Nijole

机构信息

School of Pharmacy & Pharmacology and Quality Use of Medicines Network, Griffith University, 4222 Queensland, Australia.

出版信息

J Clin Med. 2019 Jun 17;8(6):863. doi: 10.3390/jcm8060863.

DOI:10.3390/jcm8060863
PMID:31212944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6617501/
Abstract

BACKGROUND

Warfarin has long been the only oral anticoagulant (OAC) available, but options now include non-vitamin K antagonists. Prescribing an OAC may be influenced by patient factors and preferences influenced by dosing, monitoring, and adverse effects, which may ultimately impact patient satisfaction and convenience. The aim of this study was to explore the perception of OAC treatment by Australian patients in terms of treatment expectations, convenience, and satisfaction.

METHODS

The Perception of Anticoagulant Treatment Questionnaire was distributed to patients dispensed OAC medication from three pharmacies in South-East Queensland. Responses to questions using a five-point Likert scale were collated and mean results utilised to assess expectations, convenience, and satisfaction, including an analysis across demographic groups.

RESULTS

A total of 56 (26.8%) surveys were returned, with the majority of respondent's male (58.2%). Highest mean scores for treatment expectation were for an OAC that was easy to take (4.85 ± 0.79) and that could be taken care of by the respondents themselves (4.11 ± 1.14). The mean overall score for convenience was 68.90 ± 11.44% and for satisfaction 69.43 ± 16.58%. Significantly higher mean convenience scores were found in females and patients with atrial fibrillation.

CONCLUSIONS

Patients' highest expectations were for an OAC that would be easy to take, and overall satisfaction and convenience was around 69%. Factors including demographics can influence perceptions of therapy, and addressing individual preferences for OAC therapy may increase ratings of satisfaction and convenience.

摘要

背景

长期以来,华法林一直是唯一可用的口服抗凝剂(OAC),但现在有了非维生素K拮抗剂等选择。开具OAC可能会受到患者因素以及给药、监测和不良反应所影响的偏好的影响,这最终可能会影响患者的满意度和便利性。本研究的目的是从治疗期望、便利性和满意度方面探讨澳大利亚患者对OAC治疗的看法。

方法

向昆士兰州东南部三家药房配发OAC药物的患者发放抗凝治疗认知调查问卷。对使用五点李克特量表的问题回答进行整理,并利用平均结果评估期望、便利性和满意度,包括对不同人口统计学群体的分析。

结果

共收回56份(26.8%)调查问卷,大多数受访者为男性(58.2%)。治疗期望的最高平均分是针对易于服用的OAC(4.85±0.79)以及受访者自己能够处理的OAC(4.11±1.14)。便利性的平均总分是68.90±11.44%,满意度的平均总分是69.43±16.58%。女性和房颤患者的便利性平均得分显著更高。

结论

患者的最高期望是有易于服用的OAC,总体满意度和便利性约为69%。包括人口统计学在内的因素会影响对治疗的看法,关注OAC治疗的个体偏好可能会提高满意度和便利性评分。

相似文献

1
Treatment Expectations, Convenience, and Satisfaction with Anticoagulant Treatment: Perceptions of Patients in South-East Queensland, Australia.抗凝治疗的治疗期望、便利性及满意度:澳大利亚昆士兰州东南部患者的认知
J Clin Med. 2019 Jun 17;8(6):863. doi: 10.3390/jcm8060863.
2
Anticoagulation knowledge in patients with atrial fibrillation: An Australian survey.心房颤动患者的抗凝知识:一项澳大利亚调查。
Int J Clin Pract. 2018 Mar;72(3):e13072. doi: 10.1111/ijcp.13072. Epub 2018 Feb 19.
3
Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism - The SWAN Study.静脉血栓栓塞症抗凝延长治疗患者换用直接口服抗凝剂后对患者满意度的影响:SWAN 研究。
PLoS One. 2020 Jun 4;15(6):e0234048. doi: 10.1371/journal.pone.0234048. eCollection 2020.
4
Values and Preferences of Physicians and Patients With Nonvalvular Atrial Fibrillation Who Receive Oral Anticoagulation Therapy for Stroke Prevention.非瓣膜性心房颤动患者接受口服抗凝治疗预防卒中的价值观和偏好。
Can J Cardiol. 2016 Jun;32(6):747-53. doi: 10.1016/j.cjca.2015.09.023. Epub 2015 Nov 10.
5
Impact of Vitamin K Antagonists on Quality of Life in a Prospective Cohort of 807 Atrial Fibrillation Patients.维生素K拮抗剂对807例心房颤动患者前瞻性队列生活质量的影响。
Circ Cardiovasc Qual Outcomes. 2016 Jul;9(4):388-94. doi: 10.1161/CIRCOUTCOMES.115.002612. Epub 2016 Jun 21.
6
Patient Satisfaction with Direct Oral Anticoagulants and Warfarin.患者对直接口服抗凝剂和华法林的满意度。
Int Heart J. 2018 Nov 28;59(6):1266-1274. doi: 10.1536/ihj.17-649. Epub 2018 Oct 25.
7
Physicians' Perceptions of Their Patients' Attitude and Knowledge of Long-Term Oral Anticoagulant Therapy in Bulgaria.保加利亚医生对患者长期口服抗凝治疗的态度和知识的看法。
Medicina (Kaunas). 2019 Jun 26;55(7):313. doi: 10.3390/medicina55070313.
8
Exploring the Quality of Anticoagulant Prescribed for Patients With Atrial Fibrillation at the St John of God Hawkesbury District Health Centre, New South Wales, Australia.探讨澳大利亚新南威尔士州圣约翰霍克斯伯里地区卫生中心为房颤患者开具的抗凝药物质量。
J Cardiovasc Pharmacol Ther. 2019 Jan;24(1):46-53. doi: 10.1177/1074248418786264. Epub 2018 Jul 1.
9
Adherence to Oral Anticoagulants in Atrial Fibrillation: An Australian Survey.心房颤动患者口服抗凝剂的依从性:一项澳大利亚调查。
J Cardiovasc Pharmacol Ther. 2018 Jul;23(4):337-343. doi: 10.1177/1074248418770201. Epub 2018 Apr 15.
10
Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis.经皮冠状动脉介入治疗(PCI)后伴有心房颤动患者的口服抗凝药物转换:RE-DUAL PCI 试验亚组分析。
JACC Cardiovasc Interv. 2019 Dec 9;12(23):2331-2341. doi: 10.1016/j.jcin.2019.08.039.

引用本文的文献

1
Development and psychometric evaluation of the hospitalized patients' expectations for treatment scale-patient version-satisfaction scale.住院患者治疗期望量表-患者版-满意度量表的编制与心理测量学评价
BMC Health Serv Res. 2025 Aug 29;25(1):1152. doi: 10.1186/s12913-025-13287-3.
2
The Influence of Frailty Syndrome and Dementia on the Convenience and Satisfaction with Oral Anticoagulation Treatment in Elderly Patients with Atrial Fibrillation.衰弱综合征和痴呆对老年房颤患者口服抗凝治疗便利性和满意度的影响。
Int J Environ Res Public Health. 2022 Apr 28;19(9):5355. doi: 10.3390/ijerph19095355.
3
Satisfaction With Oral Anticoagulants Among Patients With Atrial Fibrillation: A Prospective Observational Study.心房颤动患者对口服抗凝剂的满意度:一项前瞻性观察研究。
CJC Open. 2021 Jun 29;3(11):1347-1356. doi: 10.1016/j.cjco.2021.06.015. eCollection 2021 Nov.

本文引用的文献

1
Patient Satisfaction with Direct Oral Anticoagulants and Warfarin.患者对直接口服抗凝剂和华法林的满意度。
Int Heart J. 2018 Nov 28;59(6):1266-1274. doi: 10.1536/ihj.17-649. Epub 2018 Oct 25.
2
Effectiveness and safety of self-managed oral anticoagulant therapy compared with direct oral anticoagulants in patients with atrial fibrillation.与直接口服抗凝剂相比,房颤患者自我管理的口服抗凝治疗的有效性和安全性。
Sci Rep. 2018 Oct 25;8(1):15805. doi: 10.1038/s41598-018-33531-7.
3
Relation between health literacy, self-care and adherence to treatment with oral anticoagulants in adults: a narrative systematic review.健康素养、自我护理与成年人口服抗凝剂治疗依从性的关系:叙事系统评价。
BMC Public Health. 2018 Oct 4;18(1):1157. doi: 10.1186/s12889-018-6070-9.
4
Patients' Priorities for Oral Anticoagulation Therapy in Non-valvular Atrial Fibrillation: a Multi-criteria Decision Analysis.非瓣膜性心房颤动患者口服抗凝治疗的优先事项:多准则决策分析。
Am J Cardiovasc Drugs. 2018 Dec;18(6):493-502. doi: 10.1007/s40256-018-0293-0.
5
Warfarin control in patients transitioning to warfarin after non-vitamin K oral anticoagulant (NOAC) therapy.华法林治疗非维生素 K 拮抗剂口服抗凝剂(NOAC)治疗后转为华法林的患者的抗凝控制。
J Thromb Thrombolysis. 2018 Nov;46(4):461-465. doi: 10.1007/s11239-018-1719-x.
6
Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) study.依度沙班治疗可提高治疗满意度并减少医疗资源的利用:来自房颤患者电复律(ENSURE-AF)研究中依度沙班与华法林的对比分析。
Europace. 2018 Dec 1;20(12):1936-1943. doi: 10.1093/europace/euy141.
7
Adherence, knowledge, and perception about oral anticoagulants in patients with atrial fibrillation at high risk for thromboembolic events after radiofrequency ablation.在射频消融术后有发生血栓栓塞事件高风险的房颤患者中,关于口服抗凝剂的依从性、知识和认知。
J Adv Nurs. 2018 Nov;74(11):2577-2587. doi: 10.1111/jan.13780. Epub 2018 Aug 30.
8
Patients' Perception of Newly Initiated Oral Anticoagulant Treatment for Atrial Fibrillation: an Observational Study.患者对新启动的心房颤动口服抗凝治疗的认知:一项观察性研究。
J Gen Intern Med. 2018 Aug;33(8):1239-1241. doi: 10.1007/s11606-018-4457-z.
9
Atrial fibrillation patient preferences for oral anticoagulation and stroke knowledge: Results of a conjoint analysis.心房颤动患者对口服抗凝治疗的偏好及中风知识:联合分析结果
Clin Cardiol. 2018 Jun;41(6):855-861. doi: 10.1002/clc.22971. Epub 2018 Jun 12.
10
Oral anticoagulant use in cardiovascular disorders: a perspective on present and potential indications for rivaroxaban.口服抗凝药物在心血管疾病中的应用:利伐沙班目前和潜在适应证的观点。
Curr Med Res Opin. 2018 Nov;34(11):1945-1957. doi: 10.1080/03007995.2018.1467885. Epub 2018 May 21.